Weekly Paclitaxel Combined with Local Hyperthermia in the Therapy of Breast Cancer Locally Recurrent after Mastectomy – a Pilot Experience

Z. Zoul; S. Filip; B. Melichar; J. Dvořák; K. Odrážka; J. Petera

doi:10.1159/000079093

Weekly Paclitaxel Combined with Local Hyperthermia in the Therapy of Breast Cancer Locally Recurrent after Mastectomy – a Pilot Experience

Oncology Research and Treatment ◽

10.1159/000079093 ◽

2004 ◽

Vol 27 (4) ◽

pp. 385-388 ◽

Cited By ~ 13

Author(s):

Z. Zoul ◽

S. Filip ◽

B. Melichar ◽

J. Dvořák ◽

K. Odrážka ◽

...

Keyword(s):

Breast Cancer ◽

Weekly Paclitaxel ◽

Local Hyperthermia ◽

Pilot Experience ◽

Locally Recurrent

Download Full-text

Bevacizumab (Bev) combined with either capecitabine (X) or weekly paclitaxel (Pac) as first-line chemotherapy (CT) for HER2-negative, locally recurrent or metastatic breast cancer (LR/MBC): Preliminary safety data from the CECOG phase III TURANDOT trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1126 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1126-1126 ◽

Cited By ~ 1

Author(s):

I. Lang ◽

M. J. Inbar ◽

R. Greil ◽

G. G. Steger ◽

S. Beslija ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Safety Data ◽

Metastatic Breast ◽

Phase Iii ◽

Weekly Paclitaxel ◽

First Line ◽

Locally Recurrent ◽

Line Chemotherapy

Download Full-text

Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-014-2652-0 ◽

2014 ◽

Vol 75 (2) ◽

pp. 401-410 ◽

Cited By ~ 3

Author(s):

Marie T. Borin ◽

Meng Chen ◽

Simonetta Mocci ◽

Igor Rubets ◽

Jason Chittenden ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Weekly Paclitaxel ◽

Locally Recurrent

Download Full-text

Abstract P2-16-01: A randomized, phase II, multicenter, double-blind, placebo-controlled trial evaluating onartuzumab with or without bevacizumab in combination with weekly paclitaxel in locally recurrent or metastatic triple-negative breast cancer (TNBC)

10.1158/0008-5472.sabcs13-p2-16-01 ◽

2013 ◽

Cited By ~ 5

Author(s):

V Dieras ◽

D Yardley ◽

G Romieu ◽

V Valero ◽

S Isakoff ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Controlled Trial ◽

Weekly Paclitaxel ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Phase Ii ◽

Locally Recurrent

Download Full-text

5058 Bevacizumab (Bev) combined with either capecitabine (X) or weekly paclitaxel (Pac) as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer (LR/MBC): the CECOG phase III TURANDOT trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70950-4 ◽

2009 ◽

Vol 7 (2) ◽

pp. 277-278

Author(s):

I. Lang ◽

M. Inbar ◽

G. Steger ◽

R. Greil ◽

Z. Zvirbule ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Weekly Paclitaxel ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Locally Recurrent

Download Full-text

A Prospective, Belgian Multi-center, Single-arm, Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04224922 ◽

2020 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Study ◽

Stage Ii ◽

Weekly Paclitaxel ◽

Dose Dense

Download Full-text

Salvage of locally recurrent breast cancer with repeat breast conservation using 45 Gy hyperfractionated partial breast re-irradiation

Breast Cancer Research and Treatment ◽

10.1007/s10549-021-06206-7 ◽

2021 ◽

Author(s):

Ishita Chen ◽

Astrid M. Botty Van den Bruele ◽

Erin F. Gillespie ◽

Boris A. Mueller ◽

Amy J. Xu ◽

...

Keyword(s):

Breast Cancer ◽

Breast Conservation ◽

Recurrent Breast Cancer ◽

Locally Recurrent ◽

Recurrent Breast

Download Full-text

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-2923-9 ◽

2014 ◽

Vol 146 (2) ◽

pp. 321-328 ◽

Cited By ~ 32

Author(s):

Kristi McIntyre ◽

Joyce O’Shaughnessy ◽

Lee Schwartzberg ◽

Stefan Glück ◽

Erhan Berrak ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor Receptor ◽

Phase 2 ◽

First Line ◽

Eribulin Mesylate ◽

First Line Therapy ◽

Line Therapy ◽

Phase 2 Study ◽

Epidermal Growth ◽

Locally Recurrent

Download Full-text

459 Weekly paclitaxel: an effective and well tolerated treatment for advanced breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90491-5 ◽

2003 ◽

Vol 1 (5) ◽

pp. S140

Author(s):

P. Kellokumpu-Lehtinen ◽

R. Asola ◽

L. Elomaa ◽

M. Heikkinen ◽

R. Kokko ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Weekly Paclitaxel

Download Full-text

Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice

Surgery Today ◽

10.1007/s00595-007-3730-2 ◽

2008 ◽

Vol 38 (10) ◽

pp. 911-920 ◽

Cited By ~ 5

Author(s):

Yoshiaki Kanaya ◽

Hiroyoshi Doihara ◽

Kouji Shiroma ◽

Yutaka Ogasawara ◽

Hiroshi Date

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Nude Mice ◽

Breast Cancer Cells ◽

Combined Therapy ◽

Local Hyperthermia

Download Full-text

Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-021-04245-x ◽

2021 ◽

Author(s):

Filipa Lynce ◽

James T. Williams ◽

Meredith M. Regan ◽

Craig A. Bunnell ◽

Rachel A. Freedman ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase I ◽

Phase I Study ◽

Metastatic Breast ◽

Weekly Paclitaxel

Download Full-text